Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality may soothe Stroke-Related agitation

NCT ID NCT07787910

Symptom relief Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether virtual reality (VR) relaxation sessions can reduce agitation in people who recently had a stroke. Participants are randomly assigned to receive either standard stroke care plus VR sessions or standard care alone. Researchers measure agitation levels and vital signs like heart rate and blood pressure before and after the sessions to see if VR helps calm patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality relaxation and distraction sessions
What this could lead to
If effective, VR could become a drug-free way to ease agitation and stabilize vital signs in stroke patients during the acute phase.
What could go wrong
This is a small, early-stage trial, and results may not apply broadly. VR may not reduce agitation, and some patients may find it uncomfortable or disorienting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

68 people

The number who actually took part.

Started

Sep 2025

Finished

Jun 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \* Individuals who have passed 48 hours post-acute CVA (being in the acute phase of stroke treatment, stroke duration not exceeding the first 4 weeks) * Having a score of 0 on the Wong-Baker FACES Pain Rating Scale * Having a score of at least +2 or higher on the Richmond Agitation-Sedation Scale (RASS) * Being 18 years of age or older * Having a GCS score of 13 or higher * Having no hearing or visual impairments * Not being in contact isolation due to a contagious disease * Being literate in Turkish * Not being administered sedation * Being awake and hemodynamically stable * Being able to sit in high Fowler's position * Individuals without mechanical ventilation support Exclusion Criteria: * Presence of nausea and vomiting * Mobility restriction and sensitivity to claustrophobia * Presence of delirium * Presence of schizophrenia and dementia * Presence of vertigo and Meniere's disease * Having a pain score of 1 point or higher * Having facial damage to the extent that a virtual reality headset cannot be worn

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychomotor Agitation stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute stroke Psychomotor agitation

Contacts and locations

Locations

  • Çankırı Karatekin University

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.